YOLFTbeta
Shenzhen YHLO Biotech Co. Ltd. A

Shenzhen YHLO Biotech Co. Ltd. A

688575 · SHG · Healthcare / Medical Devices

10.60CNY-0.19 (-1.76%)

Price History

Full chart

Market Stats

Previous Close10.79
Open10.74
Day Range10.55 – 10.98
52-Week Range8.34 – 16.96
Volume7.20M
Market Cap6.02B
P/E (TTM)95.73
Forward P/E0.00
EPS0.11
Dividend Yield0.20%
Beta0.21
50-Day Avg9.70
200-Day Avg12.13

About

Shenzhen YHLO Biotech Co., Ltd. researches, develops, produces, sells, and services in vitro diagnostic instruments and reagents in China and internationally. It offers chemiluminescence immunoassay analyzer, diabetes instruments and related reagents, automated biochemical analyzer, laboratory automation, tenfly phoenix blot analyzer, VISION Pro ESR analyzer, and VISION ESR analyzer. The company was founded in 2008 and is headquartered in Shenzhen, China.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Yongbo Song
  • Employees1.69K
  • HeadquartersBuilding 1, Baolong, 2nd Road, Shenzhen, China, 518116, China
  • Websitehttps://www.szyhlo.com

Leadership

  • Mr. Yongbo SongGM & Vice Chairman of the Board · b. 1984
  • Mr. Lisheng LiaoCFO & Director · b. 1979
  • Mr. Chun Gen QianDeputy GM & Director · b. 1982
  • Mr. Yujing XiaoDeputy General Manager · b. 1976
  • Ming Min ZhaoHead of Accounting

Financials

Income Statement

Currency: CNY2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue530.06M728.64M877.36M999.01M1.18B3.98B2.05B2.01B1.81B
Growth (%)-+37.46%+20.41%+13.87%+17.91%+237.95%-48.42%-2.02%-10.07%
Cost of Revenue335.90M445.51M440.97M433.92M530.16M1.94B949.06M720.07M636.56M
Gross Profit194.16M283.14M436.39M565.09M647.73M2.04B1.10B1.29B1.81B
Gross Margin36.63%38.86%49.74%56.57%54.99%51.34%53.77%64.20%100.00%
Operating Expense180.53M233.01M310.38M318.52M420.89M842.07M763.50M976.46M1.70B
Operating Income13.63M50.13M126.01M246.57M226.84M1.20B340.55M315.09M110.40M
Operating Margin2.57%6.88%14.36%24.68%19.26%30.19%16.59%15.66%6.10%
EBITDA27.60M80.50M193.51M324.48M339.15M1.34B530.90M566.57M333.19M
EBITDA Margin5.21%11.05%22.06%32.48%28.79%33.68%25.86%28.16%18.42%
Net Income5.89M38.03M107.54M210.53M204.75M1.01B355.01M301.53M24.02M
Net Income Margin1.11%5.22%12.26%21.07%17.38%25.43%17.29%14.99%1.33%
R&D41.41M53.22M81.50M103.18M130.74M240.31M317.18M336.71M304.92M
R&D as % of Total Revenue7.81%7.30%9.29%10.33%11.10%6.04%15.45%16.74%16.85%
Interest Expense1.54M5.04M17.72M13.48M12.08M9.48M7.51M15.39M22.89M
Interest Expense % of Total Revenue0.29%0.69%2.02%1.35%1.03%0.24%0.37%0.77%1.27%

Balance Sheet

Currency: CNY2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets593.25M838.36M1.08B1.32B2.14B4.21B3.81B4.42B4.29B
Total Liabilities298.45M505.53M497.28M559.45M623.59M1.77B1.27B1.71B1.60B
Total Equity294.80M332.83M579.40M767.79M1.53B2.42B2.56B2.76B2.70B
Cash85.65M64.16M130.68M232.36M478.85M1.25B490.59M464.97M407.25M
Total Debt81.38M234.59M271.32M306.71M233.69M473.55M556.53M880.15M-
Net Debt-4.27M170.43M140.63M74.35M-245.16M-777.01M65.94M415.17M460.06M

Cash Flow

Currency: CNY2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow8.67M29.71M68.34M282.16M259.62M1.58B-64.09M529.90M421.85M
Investing Cash Flow-94.24M-184.32M-146.54M-167.76M-461.08M-869.83M-603.60M-748.52M-
Financing Cash Flow50.05M133.55M142.44M-8.76M447.55M13.47M-59.64M180.71M-
Capital Expenditure83.02M186.39M128.09M189.39M372.66M565.37M662.71M593.31M359.24M
Free Cash Flow-74.35M-156.68M-59.75M92.76M-113.04M1.02B-735.90M-63.41M62.61M
Dividends Paid14.28M10.46M1.00M21.84M10.90M162.00M255.66M169.03M141.58M
FCF to OCF-857.61%-527.39%-87.43%32.88%-43.54%64.29%1148.24%-11.97%14.84%
Dividend Paid to FCF-19.21%-6.67%-1.67%23.54%-9.64%15.92%-34.74%-266.57%226.13%

Earnings

Report DateOct 29, 2021Feb 19, 2022Apr 28, 2022Jul 20, 2022Oct 28, 2022Feb 27, 2023Apr 28, 2023
EPS Estimate-------
EPS Actual0.120.090.900.270.370.250.14
Surprise-------
TimingPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hours

Key Statistics & Ratios

Market Cap6.02B
Enterprise Value6.27B
Trailing P/E95.73
Forward P/E0.00
Price / Sales3.18
Price / Book2.18
EPS0.11
Book Value4.82
Revenue (TTM)1.89B
Gross Profit (TTM)1.19B
EBITDA513.77M
Profit Margin3.56%
Operating Margin11.75%
Return on Equity4.32%
Return on Assets3.09%
Shares Outstanding571.42M
Shares Float295.70M
Beta0.21
Dividend Yield0.20%
Dividend Rate0.02
Payout Ratio19.09%

Dividends

20261×
0.02Jun 12, 2026
20251×
0.21Jun 27, 2025
20241×
0.27Jul 5, 2024
20231×
0.45Jun 16, 2023
20221×
0.40Jun 2, 2022

Stock Splits

  • Jun 2, 20221.4:1